first-line axicabtagene ciloleucel in lymphoma
Published 3 years ago • 123 plays • Length 0:34Download video MP4
Download video MP3
Similar videos
-
1:23
axicabtagene ciloleucel in the real-world: safety and efficacy
-
2:24
zuma-1: a pivotal trial of axicabtagene ciloleucel (axi-cel; kte-c19) in patients with nhl
-
3:10
the consa consortium: advancing newborn screening & early intervention for scd in ssa
-
3:16
first-line treatment for mcl and selecting between available options
-
6:28
outcomes following first-line therapy in routine clinical practice in alcl
-
2:45
the value of axi-cel as a second-line treatment in r/r lbcl
-
3:48
results from the first-in-human trial of tg-1801 in patients with b-cell lymphoma
-
4:03
subcutaneous mosunetuzumab as first-line therapy in high tumor-burden follicular lymphoma
-
8:50
clinical trials vs observational studies
-
3:54
a case study from the ecog-e1910 trial: early blinatumomab treatment in all
-
6:21
what exciting updates on maintenance therapy in aml were presented at ash 2023?
-
1:12
the evolving role of allosct in treatment of lymphoma
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:44
triangle: ibrutinib with soc or as a substitute to autologous transplantation in first-line mcl
-
1:34
recent and upcoming data on axi-cel for patients with nhl
-
1:55
first-line venetoclax plus hma vs intensive chemotherapy in older adults with idh-mutated aml
-
2:40
epic update: observational study of first-line acalabrutinib treatment for cll
-
0:56
cnty-101 in follicular lymphoma: a case study from the elipse-1 trial
-
2:04
imc-001: preliminary results of novel pd-l1 inhibitor for r/r extranodal nk/t cell lymphoma
-
2:14
novel approaches to first line cll treatment
-
3:46
a phase ib/ii trial of sonrotoclax plus dexamethasone in patients with r/r mm harboring t(11;14)